| 产品名称： | Streptococcus pyogenes Rosenbach |
|---|---|
| 商品货号： | TS148952 |
| Strain Designations： | M-3 DLS 88002, Weller |
| Application： | Produces streptococcal superantigen SSA Characterization of ssa gene Emerging infectious disease research |
| Isolation： | Blood - human Boise Idaho, United States |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Lancefields group A |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Isolation, patient 1 |
| Medium： | ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 37.0°C Atmosphere:xa0 Aerobicxa0 |
| Name of Depositor： | DL Stevens |
| References： | Stevens DL, et al. Severe group A streptococcal infections associated with a toxic shock- like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321: 1-7, 1989. PubMed: 2659990 Mollick JA, et al. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 92: 710-719, 1993. PubMed: 8349810 Reda KB, et al. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect. Immun. 62: 1867-1874, 1994. PubMed: 8168951 blood of 66-year-old male with streptococcal toxic shock syndrome, Boise |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Streptococcus pyogenes Rosenbach |
|---|---|
| 商品货号： | TS148952 |
| Strain Designations： | M-3 DLS 88002, Weller |
| Application： | Produces streptococcal superantigen SSA Characterization of ssa gene Emerging infectious disease research |
| Isolation： | Blood - human Boise Idaho, United States |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Lancefields group A |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Isolation, patient 1 |
| Medium： | ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 37.0°C Atmosphere:xa0 Aerobicxa0 |
| Name of Depositor： | DL Stevens |
| References： | Stevens DL, et al. Severe group A streptococcal infections associated with a toxic shock- like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321: 1-7, 1989. PubMed: 2659990 Mollick JA, et al. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 92: 710-719, 1993. PubMed: 8349810 Reda KB, et al. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect. Immun. 62: 1867-1874, 1994. PubMed: 8168951 blood of 66-year-old male with streptococcal toxic shock syndrome, Boise |
